🧠 MS-Related Fatigue Management Simulator
A model of energy balance in multiple sclerosis-related fatigue with parameters for amantadine, modafinil, and strategies for energy conservation.
Baseline MS Fatigue — Disproportionate Daily Energy Drain
MS fatigue drains energy far faster than normal daily activity should.
- ~80%: Patients affected (report significant fatigue)
- ~50%: Reported as worst symptom (ranks above mobility loss)
- 2–3×: Onset vs. normal tiredness (faster reserve depletion)
- <20%: Crash threshold (reserve triggers severe fatigue)
Why MS fatigue outpaces normal tiredness
Demyelination raises the energy cost of every neural signal sent.
The unmanaged depletion curve
Reserve falls steeply, crossing the crash zone well before evening.
Unmanaged, ordinary chores alone can trigger a fatigue crash by midday.
Energy Conservation — Pacing, Breaks, and Task Prioritization
Pacing activities and scheduled rest breaks stretch the usable energy budget.
- up to 55%: Pacing benefit (reduction in excess drain)
- 3: Core techniques (pacing, prioritizing, resting)
- ~90 min: Rest-break interval (recommended micro-breaks)
- >70%: Adherence target (for visible curve flattening)
The "energy envelope" concept
Stay inside a daily energy budget instead of pushing through fatigue.
Prioritizing and delegating tasks
Non-essential draws get trimmed, saving reserve for priority activities.
Amantadine and Modafinil — Pharmacologic Wakefulness Support
Wakefulness-promoting agents ease the excess fatigue burden pharmacologically.
- ~35%: Amantadine effect size (modest fatigue reduction)
- ~55%: Modafinil effect size (stronger wakefulness support)
- 2–4 wks: Typical onset (to full benefit)
- first/second line: Common use (MS fatigue pharmacotherapy)
Amantadine — modest, well-tolerated option
An older antiviral repurposed for mild-to-moderate MS fatigue relief.
Modafinil — stronger wakefulness agent
A stimulant-like agent offering larger gains in sustained alertness.
Medication alone helps, but pairing it with pacing works best.
Combined Approach — Behavioral Pacing Plus Medication
Stacking pacing with medication extends the usable daily energy envelope.
- up to 80%: Combined benefit (reduction in excess drain)
- large: Crash risk reduction (vs. either strategy alone)
- markedly higher: Reserve at day end (than baseline curve)
- multimodal: Approach type (behavioral + pharmacologic)
Synergy between pacing and medication
Each strategy blunts a different part of the depletion curve.
Sustaining function across the full day
Combined support keeps reserve above the crash line into evening.
Outcome — A Better-Managed Daily Energy Envelope
Well-managed energy allows sustained function without a fatigue crash.
- >40%: Reserve at day end (vs. near-zero unmanaged)
- most days: Crash events avoided (with adherence maintained)
- full schedule: Functional activities sustained (work + exercise + chores)
- improved: Quality of life (self-reported outcome measure)
What a managed day looks like
Reserve dips at each activity but recovers instead of collapsing.
Maintaining the routine long-term
Consistency in pacing and medication sustains this outcome daily.
The goal is not zero fatigue — it is staying out of the crash zone.
A model of energy balance in multiple sclerosis-related fatigue with parameters for amantadine, modafinil, and strategies for energy conservation.
2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install